PHILADELPHIA — Gastrointestinal (GI) bleeding after percutaneous coronary intervention (PCI) among patients on dual antiplatelet therapy (DAPT) remains risky in terms of morbidity and mortality, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback